There will be updates at the end of September, and the end of October.
"September 27 – 28, 2016
Dr James Garner, CEO of Novogen,
will present a corporate update at the
16th Annual Biotech in Europe Forum
for Global Partnering & Investment in
Basel, Switzerland.
October 24-26, 2016
Dr James Garner, will present a
corporate update at AusBiotech
2016 (Australia Biotech Invest) in
Melbourne, Victoria. "
Ann: Novogen submits IND Application to the FDA for Cantrixil-NRT.AX, page-70
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)